Pharming Group N.V. (PHAR)
NASDAQ·Healthcare·Biotechnology
$16.36
-0.40%
Mkt Cap $1.17B
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (3 analysts)
$39.50
Range $37.00 – $42.00
Implied Upside
+141.5%
Consensus $39.50 vs current $16.36
NASDAQ·Healthcare·Biotechnology
$16.36
-0.40%
Mkt Cap $1.17B
Buy
2
Hold
0
Sell
0
Price Target (3 analysts)
$39.50
Range $37.00 – $42.00
+141.5%
Consensus $39.50 vs current $16.36